Article Abstract

Surgery compared to stereotactic body radiation therapy for earlystage non-small cell lung cancer: better, equivalent or worse?

Authors: Paul E. Van Schil

Abstract

Surgical resection of early-stage non-small cell lung cancer (NSCLC) yields good long-term results on the condition that a complete R0 resection is performed according to the definition elaborated by a task force of the International Association for the Study of Lung Cancer (IASLC) (1). In 1995, after the study of the Lung Cancer Study Group (LCSG), which is the only phase III randomized controlled trial that has been published as full paper until now, lobectomy became the minimal resection and standard therapy for early-stage NSCLC (2,3).